• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Forestar Real Estate Group LLC

Forestar Real Estate Group LLC

Forestar Group Inc FOR

Last Price$13.71Day Change (%)-0.44%
Open Price$13.83Day Change ($)-0.06
Day Range13.58–13.9252-Week Range13.14–20.98

As of Mon 01/26/2015 02:45 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. BNC Bancorp Announces Record Earnings for Fourth Quarter and Full Year 2014

    BNC Bancorp Announces Record Earnings for Fourth Quarter and Full Year 2014

  2. Frost & Sullivan Recognizes AT&T For Leadership In Internet And Video Services

    Frost & Sullivan Recognizes AT&T For Leadership In Internet And Video Services

  3. ICE Benchmark Administration Introduces New Calculation Methodology for ISDAFIX from February 16, 2015

    ICE Benchmark Administration Introduces New Calculation Methodology for ISDAFIX from February 16, 2015

  4. Illinois Retirement Initiative Could Blaze a Path for Other States

    Will the Land of Lincoln soon be known for something other than Al Capone and imprisoned former governors?

  5. Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome

    Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome

  6. UPDATE: Never pay full price for movie tickets again

    UPDATE: Never pay full price for movie tickets again

  7. PSEG Long Island Prepares for Blizzard Conditions and Heavy Snow

    PSEG Long Island Prepares for Blizzard Conditions and Heavy Snow

  8. Nat Geo WILD’s Fully Inflated Fish Bowl II Set for Super Bowl Sunday

    Nat Geo WILD’s Fully Inflated Fish Bowl II Set for Super Bowl Sunday

  9. Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

    Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

  10. Ex-Lehman Trader Continues Fight for $84.8 Million Bonus

    Ex-Lehman Trader Continues Fight for $84.8 Million Bonus

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.